Co-Authors
This is a "connection" page, showing publications co-authored by Xiaoneng Mo and Linghua Li.
Connection Strength
0.277
-
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med (N Y). 2020 Dec 18; 1(1):105-113.e4.
Score: 0.221
-
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol Immunol. 2020 11; 17(11):1119-1125.
Score: 0.057